Omega-3 Fish Oil Improves Lupus Symptoms, Shows Possible Cardiovascular Benefits: Presented at ACR
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Omega-3 Fish Oil Improves Lupus Symptoms, Shows Possible Cardiovascular Benefits: Presented at ACR

By Bruce Sylvester

BOSTON, MA -- November 12, 2007 -- Dietary supplementation with low-dose omega-3 fish oils improves lupus symptoms and shows evidence of a protective cardiovascular effect, according to researchers.

The findings of a randomized, double-blind, placebo-controlled parallel trial of the effect of omega-3-polyunsaturated fatty acids on patients with systemic lupus erythematosus (SLE) were highlighted in a press briefing at the 71st annual meeting of the American College of Rheumatology (ACR) on November 9.

"This is the first study in lupus patients measuring improvements in blood vessel function," said presenter and investigator Stephen Wright, MD, Specialist Registrar in Rheumatology, Department of Therapeutics and Musculoskeletal Education and Research Unit, Queen's University Hospital, Belfast, United Kingdom.

"After 6 months we saw evidence confirming the beneficial effects of omega-3 fish oils for improving symptoms of lupus and, also, evidence of a cardioprotective effect in these patients," he added.

Sixty patients participated in the trial. They received 3 g of omega-3 fish oils daily, for 24 weeks. The investigators measured disease activity using the revised Systemic Lupus Activity Measure (SLAM-R) and the British Isles Lupus Assessment Group (BILAG) index of disease activity for SLE. Endothelial function was measured by flow mediated dilation (FMD) of the brachial artery, oxidative stress using platelet 8-isoprostanes, and analysis of platelet membrane fatty acids. Readings were conducted at baseline, 12, and 24 weeks.

The researchers reported that, in the fish oil group, there were statistically significant improvements at 24 weeks in lupus disease activity with changes in SLAM-R (P <.001), in BILAG (P <.001), and in FMD (P <.001).

The investigators also reported improvements in platelet 8-isoprostanes (P =.007).

The authors concluded, "Low-dose dietary supplementation with omega-3 fish oils in SLE not only has a therapeutic effect on disease activity but also improves endothelial function and reduces oxidative stress and may, therefore, confer cardiovascular benefits."

[Presentation title: A Randomised Placebo-Controlled Interventional Trial of Omega-3-Polyunsaturated Fatty Acids on Disease Activity and Endothelial Function in Systemic Lupus Erythematosus. Abstract: 1317]

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities